US: +1 617 696-7335 | EU: +31 317 728 104|info@ionoptix.com

Over the last decade human induced pluripotent stem cells (hiPSCs), as well as human embryonic stem cells (hESCs), have emerged as a model system complementary to classic approaches. These cells offer important advantages over typical adult ventricular cardiomyocytes, the most significant of which owing to their human genetic background. Despite their advantages, they are less mature, more amorphous, and provide poorer contrast. To broaden the marketability of our products, we have developed contrast-based algorithms within IonWizard, collectively called CytoMotion, to acquire contractility data from immature cells that lack refined structure and precise features.

Cardiac spheroids as a human model for inflammation induced cardiac dysfunction (2026)

2026-06-16T18:04:12-05:00

Athlin S, Steger N, Thazhath-Veettil J, Gentile C, Demirel I, Sirsjö A, Kienesberger PC, Nordenskjöld A, Paramel GV. Cardiac spheroids as a human model for inflammation induced cardiac dysfunction. Biofabrication. 2026 Mar 11;18(2). doi: 10.1088/1758-5090/ae4ad7.

Cardiac spheroids as a human model for inflammation induced cardiac dysfunction (2026)2026-06-16T18:04:12-05:00

RNA-binding protein SAMD4A targets FGF2 to regulate cardiomyocyte lineage specification from human embryonic stem cells (2025)

2026-06-16T18:15:23-05:00

Yi N, Wang HR, Zhu YP, Xiao T, Lin Q, Liu H, Meng YL, Sun YZ, Lin F, Hu SY, Cao HM, Zhang JF, Peng LY, Li L. RNA-binding protein SAMD4A targets FGF2 to regulate cardiomyocyte lineage specification from human embryonic stem cells. Stem Cell Res Ther. 2025 Mar 18;16(1):144. doi: 10.1186/s13287-025-04269-7.

RNA-binding protein SAMD4A targets FGF2 to regulate cardiomyocyte lineage specification from human embryonic stem cells (2025)2026-06-16T18:15:23-05:00

Mutation-induced LZTR1 polymerization provokes cardiac pathology in recessive Noonan syndrome (2024)

2026-06-16T18:55:06-05:00

Busley AV, Gutiérrez-Gutiérrez Ó, Hammer E, Koitka F, Mirzaiebadizi A, Steinegger M, Pape C, Böhmer L, Schroeder H, Kleinsorge M, Engler M, Cirstea IC, Gremer L, Willbold D, Altmüller J, Marbach F, Hasenfuss G, Zimmermann WH, Ahmadian MR, Wollnik B, Cyganek L. Mutation-induced LZTR1 polymerization provokes cardiac pathology in recessive Noonan syndrome. Cell Rep. 2024 Jul 23;43(7):114448. doi: 10.1016/j.celrep.2024.114448.

Mutation-induced LZTR1 polymerization provokes cardiac pathology in recessive Noonan syndrome (2024)2026-06-16T18:55:06-05:00

MYBPC3 D389V Variant Induces Hypercontractility in Cardiac Organoids (2024)

2026-05-15T18:57:47-05:00

Desai D, Song T, Singh RR, Baby A, McNamara J, Green LC, Nabavizadeh P, Ericksen M, Bazrafshan S, Natesan S, Sadayappan S. MYBPC3 D389V Variant Induces Hypercontractility in Cardiac Organoids. Cells. 2024 Nov 19;13(22):1913. doi: 10.3390/cells13221913.

MYBPC3 D389V Variant Induces Hypercontractility in Cardiac Organoids (2024)2026-05-15T18:57:47-05:00

Real-Time Measurements of Calcium and Contractility Parameters in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (JOVE VIDEO)(2023)

2026-05-27T10:10:01-05:00

Real-Time Measurements of Calcium and Contractility Parameters in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Dinani R, Manders E, Helmes M, Wang L, Knollmann B, Kuster DWD, van der Velden J. J Vis Exp. 2023 May 26;(195). doi: 10.3791/65326.

Real-Time Measurements of Calcium and Contractility Parameters in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (JOVE VIDEO)(2023)2026-05-27T10:10:01-05:00

Myosin Modulator Aficamten Inhibits Force by Altering Myosin’s Biochemical Activity Without Changing Thick Filament Structure (2025)

2026-05-15T18:01:07-05:00

Mohran S, Kooiker KB, Naim A, Pilagov M, Asencio A, Turner KL, Ma W, Flint G, Jiang S, Zhao J, McMillen TS, Mandrycky C, Mahoney-Schaefer M, Irving TC, Tanner BCW, Kad NM, Regnier M, Moussavi-Harami F (2025). Myosin Modulator Aficamten Inhibits Force by Altering Myosin's Biochemical Activity Without Changing Thick Filament Structure. JACC Basic Transl Sci. 2026 Jan;11(1):101449. doi: 10.1016/j.jacbts.2025.101449.

Myosin Modulator Aficamten Inhibits Force by Altering Myosin’s Biochemical Activity Without Changing Thick Filament Structure (2025)2026-05-15T18:01:07-05:00
Go to Top